TRAIN-HEART Network

The TRAIN-HEART consortium, funded by the European Commission (2019-2023), is made up to train a league of 15 promising fellows that harness novel insights in the pathogenesis of ischemic heart failure, study the therapeutic potential of existing RNA therapeutics and improve its efficacy by the design of novel drug delivery systems.


People

TRAIN-HEART brings together leading academic teams and (biotech) companies covering various disciplines ranging from fundamental research to clinical pharmacology and gene therapy to drug delivery applications, have teamed up in the European Union.


Research Programme

The TRAIN-HEART network aims to gain viable insight in the pathogenesis of ischemic heart failure which will serve as a basis for drug discovery and drug delivery efforts that aim to therapeutically target specific molecules and mechanisms within cardiomyocytes for the treatment of ischemic heart failure.  


Contact

If you have any questions you can fill in the form or mail us directly: info@train-heart.eu.





News

European Research & Innovation Days 2020

European Research and Innovation Days is the European Commission’s annual flagship Research and Innovation event, bringing together policymakers, researchers, entrepreneurs and the public to debate and shape the future of research and innovation in Europe and beyond. This year, it is a fully virtual event.

By creating connections between cutting-edge scientific research and the most pressing challenges of a generation, the European Research and Innovation Days represent a unique opportunity to join the conversation and enact real change. From tackling the climate crisis to building a digital world that works for everyone, we’ll delve into the questions that shape who we are and the future we want to live in: it’s time to get involved!

The event is all about collaboration: bringing together individuals and experts from all areas to build connections and ignite a brighter future.

More information can be found here.